What is the ticker symbol for Verve Therapeutics?

Verve Therapeutics trades under the ticker VERV on NASDAQ.

What sector does Verve Therapeutics operate in?

Verve Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VERV in a portfolio?

PortView shows VERV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Verve Therapeutics (VERV) Stock Analysis

NASDAQHealthcareBiotechnology

$11.13+0.27%

1-year price historyRange $2.97 – $11.38

52-week range$11.13

$2.87$11.41

What Verve Therapeutics does

Verve Therapeutics, Inc. is a biotechnology firm dedicated to pioneering gene-editing treatments for individuals afflicted with cardiovascular diseases. Their flagship experimental therapy, VERVE-101, represents a singular gene-editing intervention engineered to irreversibly inactivate the PCSK9 gene within the liver. The company is also progressing with an ANGPTL3 program, which similarly aims to permanently switch off the ANGPTL3 gene in the liver. To support its endeavors, Verve maintains several key partnerships, including a collaboration and licensing pact with Beam Therapeutics Inc., a development and option agreement with Acuitas Therapeutics, Inc., and a Cas9 gene-editing technology license from The Broad Institute and the President and Fellows of Harvard College. Incorporated in 2018 and headquartered in Cambridge, Massachusetts, the organization operated under the name Endcadia, Inc. until its rebranding to Verve Therapeutics, Inc. in January 2019.

Key metrics

Market cap

$994.04M

P/E (TTM)

-5.27

EPS (TTM)

$-2.11

Beta

2.24

Dividend yield

0.00%

Revenue / share

$0.38

50-day avg

$8.21

200-day avg

$6.45

52-week high

$11.41

52-week low

$2.87

CEO

Sekar Kathiresan

ETFs linked to VERV

Broad-market and Healthcare sector ETFs an investor holding Verve Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how VERV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze VERV in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Verve Therapeutics?: Verve Therapeutics trades under the ticker VERV on NASDAQ.
Which exchange is VERV listed on?: VERV is listed on NASDAQ.
What sector does Verve Therapeutics operate in?: Verve Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze VERV in a portfolio?: PortView shows VERV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.